Cargando…
Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome
Autores principales: | Bhalla, Pratibha, Du, Qiumei, Kumar, Ashwani, Xing, Chao, Moses, Angela, Dozmorov, Igor, Wysocki, Christian A., Cleaver, Ondine B., Pirolli, Timothy J., Markert, Mary Louise, de la Morena, Maria Teresa, Baldini, Antonio, van Oers, Nicolai S.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313354/ https://www.ncbi.nlm.nih.gov/pubmed/37395280 http://dx.doi.org/10.1172/JCI173145 |
Ejemplares similares
-
Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome
por: Bhalla, Pratibha, et al.
Publicado: (2022) -
Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models
por: Bhalla, Pratibha, et al.
Publicado: (2020) -
The Genetics and Epigenetics of 22q11.2 Deletion Syndrome
por: Du, Qiumei, et al.
Publicado: (2020) -
Dysregulation of DGCR6 and DGCR6 L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome
por: Chakraborty, D, et al.
Publicado: (2012) -
Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development
por: Mustillo, Peter J., et al.
Publicado: (2023)